FDA supports first generic naloxone nasal spray to treat opioid overdose
The life-sparing medication that can stop or invert the impacts of an opioid overdose may counteract a huge number of passings. Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received endorsement from the U.S. Food and Drug Administration (FDA) to showcase its generic nasal spray for opioid overdose, the health regulator said. This is the…